Navigation Links
Parker Waichman LLP Comments on Pending Debut of ‘Sunshine Act,’ Which Will Focus on Cases of Allegedly Fraudulent Financial Links Between Doctors and Manufacturers

New York, New York (PRWEB) July 17, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, comments on the expected Aug. 1 debut of the Physician Payment Sunshine Act provision of the Affordable Care Act, which is designed to highlight cases of allegedly fraudulent relationships between doctors and pharmaceutical companies and medical device manufacturers, as detailed in the Feb. 8, 2013, Federal Register.

Under the Sunshine Act, all manufacturers of pharmaceuticals, medical devices, and biologicals must report to the National Physician Payment Transparency Program at the Centers for Medicare & Medicaid Services (CMS). These outfits are compelled to report how much money they pay doctors and hospitals, as well as certain information regarding the ownership or investment interests held by physicians or their immediate family members in these companies.

Senate Finance Committee Chairman Max Baucus (D-Mont.) prominently linked the Sunshine Act with a 16-month U.S. Senate investigation that had revealed previously undisclosed ties between Medtronic and some doctors to whom it had paid $210 million to help promote and launch its Infuse bone graft product. The investigation also disclosed that Medtronic employees had collaborated with physician authors to edit, and sometimes write, clinical studies promoting Infuse for publication in medical journals. “These findings emphasize the value of the… Physician Payments Sunshine Act, which will result in public disclosure of industry payments to physicians starting next year,” said Senator Baucus, according to an Oct. 25, 2012, U.S. Senate Finance Committee release.

The Finance Committee had also found problems with most of the initial Medtronic-supported Infuse research, as noted in an Oct. 25, 2012, Bloomberg Businessweek report. The article noted that doctors and researchers had authored at least 11 medical journal reports about Infuse for their multimillion-dollar payment, which was in the form of royalties and consulting fees. Senate investigators also charged that Medtronic deliberately manipulated studies to mitigate any adverse reactions to Infuse side effects, as well as to promote off-label use.

“Ultimately, the public deserves accurate information regarding the benefits and risks associated with any medication or medical device they are considering putting inside their bodies,” said Gary Falkowitz, Managing Attorney from Parker Waichman LLP. “Examples like the Senate’s investigation into the Infuse product show the potential value of the Sunshine Act.”

Parker Waichman LLP is currently offering free legal consultations to victims of Medtronic Infuse Bone Graft Injuries. If you or a loved one suffered a serious complication or injury after receiving Medtronic Infuse, please contact their office by visiting the firm's Medtronic Infuse injury page at Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Plaintiff is Replaced in First Bellwether Trial in DePuy ASR Multidistrict Litigation, Notes Parker Waichman LLP
2. Transvaginal Mesh Multidistrict Litigation Update: Court Chooses Four Bellwether Cases for American Medical Systems, Notes Parker Waichman LLP
3. New Mexico Woman Alleges Mirena IUD Perforated Her Uterus; Parker Waichman LLP Files Lawsuit
4. Da Vinci Surgical Robot Update: FDA Issues Class 2 Recall of Intuitive Surgical’s da Vinci Robot due to Possibly Inadequate Testing of 30 Units, Notes Parker Waichman LLP
5. American Medical Systems’ Transvaginal Mesh Caused Arizona Woman’s Injuries, Alleges Lawsuit Filed by Parker Waichman LLP
6. Actos Caused Bladder Cancer and Wrongful Death of New York Woman, Alleges Lawsuit Filed by Parker Waichman LLP
7. American Medical Systems’ Transvaginal Mesh Allegedly Caused Pennsylvania Woman Severe and Painful Injuries, According to Lawsuit Filed by Parker Waichman LLP
8. Florida Man Develops Bladder Cancer as Result of Taking Actos, Alleges Lawsuit Filed by Parker Waichman LLP
9. Parker Waichman LLP Commends Arkansas Attorney General for Backing Fine Against Johnson & Johnson over Risperdal Off-Label Marketing Allegations
10. Mirena IUD Birth Control Device Perforated Kentucky Woman’s Uterus, Alleges Lawsuit Filed by Parker Waichman LLP
11. Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... by UPMC and KingMed Diagnostics researchers. Their review of ... that consultation with UPMC pathologists resulted in significantly altered treatment plans for more ...
(Date:11/30/2015)... ... 30, 2015 , ... ”Dying Words: The AIDS Reporting of Jeff Schmalz and ... to coincide with World AIDS Day. The multi-media project will be in audio documentary ... as he was dying of the disease. , A collaborative effort led by author, ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... promoting breast and prostate cancer education and prevention—is joining forces with the award-winning ... philanthropy and Hollywood elegance on December 7, 2015 at the Union League of ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... their exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage ... effective immediately. , “We are pleased to announce our expanded distribution agreement ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i ... years, announced today that Michigan-based Family Health Center (FHC) has selected i2iTracks as ... years, FHC was awarded the largest Affordable Care Act grant for Federally Qualified ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... YORK , Nov. 30, 2015 Cumberland Pharmaceuticals ... will present live at on December 3, 2015. ... --> TIME: 3:15p.m. ET LINK: ... ET LINK: --> ... online event where investors are invited to ask the company ...
(Date:11/30/2015)... Nov. 30, 2015 Varian Medical Systems (NYSE: VAR ... educational partnership with Apollo Hospitals Group, the largest hospital chain in ... help train radiation technologists in the country. The MoU was signed ... Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology: